How much did listed pharmaceutical companies spend on SG&A expenses?

This year, the increase of collective selling, general & administrative(SG&A) expenses by the 3^rd quarter of the year on average was 20 times higher in the KOSDAQ market than the one in the KOSPI. When it comes to the percentage of SG&A expenses to sales, KOSDAQ listed pharmaceutical companies had a more than 2% higher increase than KOSPI listed pharmas.

Yakup Shinmoon(www.yakup.com) analyzed ...